Bernadette Connaughton
Directeur/Membre du Conseil chez HALOZYME THERAPEUTICS, INC.
Fortune : 3 M $ au 30/04/2024
Postes actifs de Bernadette Connaughton
Sociétés | Poste | Début | Fin |
---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/09/2018 | - |
Independent Dir/Board Member | 10/09/2018 | - | |
ZEALAND PHARMA A/S | Directeur/Membre du Conseil | 04/04/2019 | - |
Independent Dir/Board Member | 04/04/2019 | - | |
EDITAS MEDICINE, INC. | Directeur/Membre du Conseil | 26/10/2021 | - |
Independent Dir/Board Member | 26/10/2021 | - | |
Boys & Girls Clubs of New Jersey | Directeur/Membre du Conseil | - | - |
Historique de carrière de Bernadette Connaughton
Anciens postes connus de Bernadette Connaughton
Sociétés | Poste | Début | Fin |
---|---|---|---|
SYNEOS HEALTH, INC. | Directeur/Membre du Conseil | 12/11/2019 | 28/09/2023 |
Independent Dir/Board Member | 12/11/2019 | 28/09/2023 | |
VISTERRA INC | Directeur/Membre du Conseil | 01/12/2015 | 01/08/2018 |
Bristol-Myers Squibb Pharma Co. | Corporate Officer/Principal | 01/01/2004 | 01/10/2017 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2004 | 01/01/2017 |
Formation de Bernadette Connaughton
The Johns Hopkins University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 10 |
Danemark | 2 |
Opérationnelle
Director/Board Member | 6 |
Independent Dir/Board Member | 4 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
ZEALAND PHARMA A/S | Health Technology |
EDITAS MEDICINE, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Visterra, Inc.
Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Syneos Health, Inc.
Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Boys & Girls Clubs of New Jersey | |
Bristol-Myers Squibb Pharma Co. |
- Bourse
- Insiders
- Bernadette Connaughton
- Expérience